$25.03
0.60% yesterday
NYSE, Dec 24, 10:49 pm CET
ISIN
US7170811035
Symbol
PFE

Pfizer Stock price

$25.03
-0.19 0.75% 1M
+0.72 2.96% 6M
-1.50 5.65% YTD
-1.71 6.39% 1Y
-26.80 51.71% 3Y
-12.24 32.84% 5Y
-5.87 19.00% 10Y
+2.33 10.28% 20Y
NYSE, Closing price Wed, Dec 24 2025
+0.15 0.60%

New AI Insights on Pfizer Insights AI Insights on Pfizer

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$142.3b
Enterprise Value
$189.0b
Net debt
$46.7b
Cash
$15.0b
Shares outstanding
5.7b
Valuation (TTM | estimate)
P/E
14.6 | 7.9
P/S
2.3 | 2.3
EV/Sales
3.0 | 3.0
EV/FCF
18.2
P/B
1.5
Dividends
DPS
$1.72
Yield 1Y | 5Y
6.9% | 4.5%
Growth 1Y | 5Y
1.8% | 3.2%
Payout 1Y | 3Y
119.9% | 68.3%
Increased
16 Years
Financials (TTM | estimate)
Revenue
$62.8b | $62.8b
EBITDA
$23.3b | $24.7b
EBIT
$18.3b | $21.7b
Net Income
$9.8b | $17.9b
Free Cash Flow
$10.4b
Growth (TTM | estimate)
Revenue
3.9% | -1.3%
EBITDA
-5.3% | 12.2%
EBIT
-5.8% | 29.8%
Net Income
131.1% | 123.1%
Free Cash Flow
26.1%
Margin (TTM | estimate)
Gross
75.0%
EBITDA
37.1% | 39.3%
EBIT
29.1%
Net
15.7% | 28.5%
Free Cash Flow
16.5%
Financial Health
Equity Ratio
41.3%
Return on Equity
9.1%
ROCE
10.6%
ROIC
12.0%
Debt/Equity
0.7
More
EPS
$1.7
FCF per Share
$1.8
Short interest
2.5%
Employees
81k
Rev per Employee
$790.0k
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Pfizer forecast:

16x Buy
48%
16x Hold
48%
1x Sell
3%

Analyst Opinions

33 Analysts have issued a Pfizer forecast:

Buy
48%
Hold
48%
Sell
3%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
62,786 62,786
4% 4%
100%
- Direct Costs 15,727 15,727
34% 34%
25%
47,059 47,059
3% 3%
75%
- Selling and Administrative Expenses 13,836 13,836
7% 7%
22%
- Research and Development Expense 10,132 10,132
3% 3%
16%
23,287 23,287
5% 5%
37%
- Depreciation and Amortization 5,004 5,004
4% 4%
8%
EBIT (Operating Income) EBIT 18,283 18,283
6% 6%
29%
Net Profit 9,828 9,828
131% 131%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Neutral
24/7 Wall Street
one day ago
Dividend stocks have been under pressure in the past few years due to the broader economy's unpredictable swings.
Negative
Reuters
2 days ago
A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
Positive
The Motley Fool
3 days ago
The pole position in the GLP-1 weight loss space is currently held by Eli Lilly. Novo Nordisk was the early leader, showing that being first doesn't always mean you stay at the head of the pack.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today